Role of Helicobacter pylori cagA EPIYA motif and vacA genotypes for the development of gastrointestinal diseases in Southeast Asian countries: A meta-analysis

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Sahara, Shu ^a   Sugimoto, Mitsushige ^a   Vilaichone, Ratha Korn ^b   Mahachai, Varocha ^c   Miyajima, Hiroaki ^a   Furuta, Takahisa ^a   Yamaoka, Yoshio ^d  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b THAMMASAT UNIVERSITY HOSPITAL   (Thailand)

^c KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^d OITA UNIVERSITY   (Japan)

Author keywords

cagA; EPIYA; Gastric cancer; Helicobacter pylori; Peptic ulcer disease; Southeast Asian; vacA

Indexed keywords

CAGA PROTEIN; VACUOLATING TOXIN;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CANCER RISK; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DYSPEPSIA; GASTROINTESTINAL DISEASE; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALAYSIA; PEPTIC ULCER; PROTEIN MOTIF; SINGAPORE; SOUTHEAST ASIA; STOMACH CANCER; THAILAND; VIET NAM;

ANTIGENS, BACTERIAL; ASIA, SOUTHEASTERN; BACTERIAL PROTEINS; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MOLECULAR EPIDEMIOLOGY; VIRULENCE FACTORS;

EID: 84866510376     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-223     Document Type: Article

References (56)

1. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001, 345(11):784-789. 10.1056/NEJMoa001999, 11556297.
2. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996, 110(4):1244-1252. 10.1053/gast.1996.v110.pm8613015, 8613015.
3. Wotherspoon AC, Doglioni C, De Boni M, Spencer J, Isaacson PG. Antibiotic treatment for low-grade gastric malt lymphoma. Lancet 1994, 343(8911):1503. 10.1016/S0140-6736(94)92613-1, 7911202.
4. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008, 372(9636):392-397. 10.1016/S0140-6736(08)61159-9, 18675689.
5. Perez-Perez GI, Taylor DN, Bodhidatta L, Wongsrichanalai J, Baze WB, Dunn BE, Echeverria PD, Blaser MJ. Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis 1990, 161(6):1237-1241. 10.1093/infdis/161.6.1237, 2345304.
6. Rocha GA, Queiroz DM, Mendes EN, Oliveira AM, Moura SB, Barbosa MT, Mendes CC, Lima Junior GF, Oliveira CA. Indirect immunofluorescence determination of the frequency of anti-H pylori antibodies in brazilian blood donors. Braz J Med Biol Res 1992, 25(7):683-689.
7. Yamaoka Y, Orito E, Mizokami M, Gutierrez O, Saitou N, Kodama T, Osato MS, Kim JG, Ramirez FC, Mahachai V, et al. Helicobacter pylori in north and south america before columbus. FEBS Lett 2002, 517(1-3):180-184.
8. Van Doorn LJ, Schneeberger PM, Nouhan N, Plaisier AP, Quint WG, De Boer WA. Importance of Helicobacter pylori caga and vacA status for the efficacy of antibiotic treatment. Gut 2000, 46(3):321-326. 10.1136/gut.46.3.321, 1727836, 10673291.
9. Sugimoto M, Yamaoka Y. The association of vacA genotype and Helicobacter pylori-related disease in latin american and african populations. Clin Microbiol Infect 2009, 15(9):835-842. 10.1111/j.1469-0691.2009.02769.x, 3118417, 19392900.
10. Sugimoto M, Zali MR, Yamaoka Y. The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East. Eur J Clin Microbiol Infect Dis 2009, 28(10):1227-1236. 10.1007/s10096-009-0772-y, 3130054, 19551413.
11. Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, Matsuhisa T, Yamada N. Genetic differences in interleukin-1 beta polymorphisms among four asian populations: an analysis of the Asian paradox between h. pylori infection and gastric cancer incidence. J Exp Clin Cancer Res 2003, 22(1):47-55.
12. Yamada S, Matsuhisa T, Makonkawkeyoon L, Chaidatch S, Kato S, Matsukura N. Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in thais. J Gastroenterol 2006, 41(12):1169-1177.
13. Lunet N, Barros H. Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer 2003, 106(6):953-960. 10.1002/ijc.11306, 12918076.
14. Miwa H, Go MF, N S. H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol 2002, 97(5):1106-1112. 10.1111/j.1572-0241.2002.05663.x, 12014714.
15. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999, 37(7):2274-2279. 85136, 10364597.
16. Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY. Importance of Helicobacter pylori oipa in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 2002, 123(2):414-424. 10.1053/gast.2002.34781, 12145793.
17. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999, 284(5418):1328-1333. 10.1126/science.284.5418.1328, 10334982.
18. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M. Shp-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori cagA protein. Science 2002, 295(5555):683-686. 10.1126/science.1067147, 11743164.
19. Broutet N, Tchamgoue S, Pereira E, Lamouliatte H, Salamon R, Megraud F. Risk factors for failure of Helicobacter pylori therapy-results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther 2003, 17(1):99-109. 10.1046/j.1365-2036.2003.01396.x, 12492738.
20. van der Hulst RW, Weel JF, Verheul SB, Keller JJ, ten Kate FJ, van der Ende A, Rauws EA, Dankert J, Tytgat GN. Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxycillin and the effect of early retreatment. Aliment Pharmacol Ther 1996, 10(2):165-171. 10.1046/j.1365-2036.1996.715895000.x, 8730245.
21. Yamaoka Y, El-Zimaity HM, Gutierrez O, Figura N, Kim JG, Kodama T, Kashima K, Graham DY. Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 1999, 117(2):342-349. 10.1053/gast.1999.0029900342, 10419915.
22. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, Hatakeyama M. Biological activity of the Helicobacter pylori virulence factor cagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A 2002, 99(22):14428-14433. 10.1073/pnas.222375399, 137900, 12391297.
23. Selbach M, Moese S, Hauck CR, Meyer TF, Backert S. Src is the kinase of the Helicobacter pylori caga protein in vitro and in vivo. J Biol Chem 2002, 277(9):6775-6778. 10.1074/jbc.C100754200, 11788577.
24. Backert S, Moese S, Selbach M, Brinkmann V, Meyer TF. Phosphorylation of tyrosine 972 of the Helicobacter pylori cagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol 2001, 42(3):631-644.
25. Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995, 270(30):17771-17777. 10.1074/jbc.270.30.17771, 7629077.
26. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, Atherton JC. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007, 133(3):926-936. 10.1053/j.gastro.2007.06.056, 17854597.
27. Kidd M, Lastovica AJ, Atherton JC, Louw JA. Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa?. Gut 1999, 45(4):499-502. 10.1136/gut.45.4.499, 1727692, 10486355.
28. Miehlke S, Kirsch C, Agha-Amiri K, Gunther T, Lehn N, Malfertheiner P, Stolte M, Ehninger G, Bayerdorffer E. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in germany. Int J Cancer 2000, 87(3):322-327. 10.1002/1097-0215(20000801)87:3<322::AID-IJC3>3.0.CO;2-M, 10897035.
29. Figueiredo C, Van Doorn LJ, Nogueira C, Soares JM, Pinho C, Figueira P, Quint WG, Carneiro F. Helicobacter pylori genotypes are associated with clinical outcome in portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol 2001, 36(2):128-135.
30. Atherton JC, Peek RM, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997, 112(1):92-99. 10.1016/S0016-5085(97)70223-3, 8978347.
31. Uchida T, Nguyen LT, Takayama A, Okimoto T, Kodama M, Murakami K, Matsuhisa T, Trinh TD, Ta L, Ho DQ, et al. Analysis of virulence factors of Helicobacter pylori isolated from a vietnamese population. BMC Microbiol 2009, 9:175. 10.1186/1471-2180-9-175, 2739534, 19698173.
32. Truong BX, Mai VT, Tanaka H, le Ly T, Thong TM, Hai HH, Van Long D, Furumatsu K, Yoshida M, Kutsumi H, et al. Diverse characteristics of the cagA gene of Helicobacter pylori strains collected from patients from South Vietnam with gastric cancer and peptic ulcer. J Clin Microbiol 2009, 47(12):4021-4028. 10.1128/JCM.00504-09, 2786673, 19846630.
33. Nguyen TL, Uchida T, Tsukamoto Y, Trinh DT, Ta L, Mai BH, Le SH, Thai KD, Ho DD, Hoang HH, et al. Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study. BMC Gastroenterol 2010, 10:114. 10.1186/1471-230X-10-114, 2959090, 20920280.
34. Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter 2004, 9(5):453-459. 10.1111/j.1083-4389.2004.00260.x, 15361085.
35. Linpisarn S, Suwan W, Lertprasertsuk N, Koosirirat C, Steger HF, Prommuangyong K, Phornphutkul K. Helicobacter pylori cagA, vacA and iceA genotypes in Northern Thai patients with gastric disease. Southeast Asian J Trop Med Public Health 2007, 38(2):356-362.
36. Chomvarin C, Namwat W, Chaicumpar K, Mairiang P, Sangchan A, Sripa B, Tor-Udom S, Vilaichone RK. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and baba2 genotypes in thai dyspeptic patients. Int J Infect Dis 2008, 12(1):30-36. 10.1016/j.ijid.2007.03.012, 17548220.
37. Tan HJ, Rizal AM, Rosmadi MY, Goh KL. Distribution of Helicobacter pylori cagA, cagE and vacA in different ethnic groups in Kuala Lumpur, Malaysia. J Gastroenterol Hepatol 2005, 20(4):589-594. 10.1111/j.1440-1746.2005.03783.x, 15836708.
38. Tan HJ, Rizal AM, Rosmadi MY, Goh KL. Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia. J Gastroenterol Hepatol 2006, 21(1 Pt 1):110-115.
39. Mohamed R, Hanafiah A, Rose IM, Manaf MR, Abdullah SA, Sagap I, Van Belkum A, Yaacob JA. Helicobacter pylori cagA gene variants in malaysians of different ethnicity. Eur J Clin Microbiol Infect Dis 2009, 28(7):865-869. 10.1007/s10096-009-0712-x, 2693772, 19247698.
40. Schmidt HM, Goh KL, Fock KM, Hilmi I, Dhamodaran S, Forman D, Mitchell H. Distinct cagA EPIYA motifs are associated with ethnic diversity in Malaysia and Singapore. Helicobacter 2009, 14(4):256-263. 10.1111/j.1523-5378.2009.00684.x, 19674129.
41. Schmidt HM, Andres S, Nilsson C, Kovach Z, Kaakoush NO, Engstrand L, Goh KL, Fock KM, Forman D, Mitchell H. The cagA PAI is intact and functional but hp0520 varies significantly in Helicobacter pylori isolates from Malaysia and Singapore. Eur J Clin Microbiol Infect Dis 2010, 29(4):439-451. 10.1007/s10096-010-0881-7, 20157752.
42. Zheng PY, Hua J, Yeoh KG, Ho B. Association of peptic ulcer with increased expression of lewis antigens but not cagA, iceA, and vacA in Helicobacter pylori isolates in an Asian population. Gut 2000, 47(1):18-22. 10.1136/gut.47.1.18, 1727977, 10861258.
43. Van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, De Boer W, Quint W. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998, 115(1):58-66. 10.1016/S0016-5085(98)70365-8, 9649459.
44. Ho YW, Ho KY, Ascencio F, Ho B. Neither gastric topological distribution nor principle virulence genes of Helicobacter pylori contributes to clinical outcomes. World J Gastroenterol 2004, 10(22):3274-3277.
45. Vivatvakin B, Theamboonlers A, Semakachorn N, Wongsawadi L. Prevalence of cagA and vacA genotype of Helicobacter pylori in Thai children. J Med Assoc Thai 2004, 87(11):1327-1331.
46. Yamaoka Y, Malaty HM, Osato MS, Graham DY. Conservation of Helicobacter pylori genotypes in different ethnic groups in Houston, Texas. J Infect Dis 2000, 181(6):2083-2086. 10.1086/315486, 10837199.
47. Ogiwara H, Sugimoto M, Ohno T, Vilaichone RK, Mahachai V, Graham DY, Yamaoka Y. Role of deletion located between intermediate- and middle-region of Helicobacter pylori vacA gene in gastroduodenal diseases. J Clin Microbiol 2009, 47(11):3493-3500. 10.1128/JCM.00887-09, 2772588, 19726606.
48. Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P, Salgado C, Belo L, Peixoto A, Bravo JC, et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 2001, 158(2):647-654. 10.1016/S0002-9440(10)64006-0, 1850299, 11159201.
49. Martins LC, Corvelo TC, Demachki S, Araujo MT, Assumpcao MB, Vilar SC, Freitas FB, Barbosa HP, Fecury AA, do Amaral RK. Clinical and pathological importance of vacA allele heterogeneity and cagA status in peptic ulcer disease in patients from north brazil. Mem Inst Oswaldo Cruz 2005, 100(8):875-881. 10.1590/S0074-02762005000800009, 16444419.
50. Breurec S, Guillard B, Hem S, Brisse S, Dieye FB, Huerre M, Oung C, Raymond J, Tan TS, Thiberge JM, et al. Evolutionary history of Helicobacter pylori sequences reflect past human migrations in Southeast Asia. PLoS One 2011, 6(7):e22058. 10.1371/journal.pone.0022058, 3139604, 21818291.
51. Higashi H, Yokoyama K, Fujii Y, Ren S, Yuasa H, Saadat I, Murata-Kamiya N, Azuma T, Hatakeyama M. EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor cagA in mammalian cells. J Biol Chem 2005, 280(24):23130-23137. 10.1074/jbc.M503583200, 15831497.
52. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori cagA protein. Nat Rev Cancer 2004, 4(9):688-694. 10.1038/nrc1433, 15343275.
53. Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, El-Zimaity HM, Reddy R, Arnqvist A, Graham DY. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 2006, 55(6):775-781. 10.1136/gut.2005.083014, 1856239, 16322107.
54. Kersulyte D, Mukhopadhyay AK, Velapatino B, Su W, Pan Z, Garcia C, Hernandez V, Valdez Y, Mistry RS, Gilman RH, et al. Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol 2000, 182(11):3210-3218. 10.1128/JB.182.11.3210-3218.2000, 94509, 10809702.
55. Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y. Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pylori cagA genotype. Scand J Gastroenterol 2005, 40(5):530-539. 10.1080/00365520510012299, 16036505.
56. Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, De Poire E, Sgouras D, Wessler S, Torres J, Smolka A, Backert S. C-src and c-abl kinases control hierarchic phosphorylation and function of the cagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest 2012, 122(4):1553-1566. 10.1172/JCI61143, 3314471, 22378042.